MSH|^~\&|MAYO CLINIC DEPT. OF LAB MED AND PATHOLOGY|MAYO CLINIC DEPT. OF LAB MED AND PATHOLOGY^2.16.840.1.113883.3.2.12.1.1^ISO|KS-MAIN|251-KS-MAIN|20201028003540-0500||ORU^R01^ORU_R01|2020102805354015005611|P|2.5.1|||NE|NE|USA||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|Lawson^L^^^^MAYO RD&2.16.840.1.113883.3.2.12.1&ISO^XX^^^99999|19.1|Cloverleaf IE|9999||20101113
PID|1|replaced 2|||Izetta651^Bailey598||19790520|F|||152 Yundt Dam^^Aurora^IL^60505|US|^PRN^PH^^1^645^5241300|||||||||||||||||
ORC|RE|H65126|F722049201|||||||||^MARTINEZ^JOHN D|7009204||||||||Univ of Kansas Hosp-LSI|2015 W 39th Ave^^Kansas City^KS^66103|^WPN^PH^^1^913^5880384
OBR|1|H65126^Placer Order Number^2.16.840.1.113883.3.2.12.1.99^ISO|F722049201^Filler Order Number^2.16.840.1.113883.3.2.12.1.1^ISO|^^^LYWB^Lyme Disease Ab, Immunoblot, S^L^^U|||202010221439|||7009204^Univ of Kansas Hosp-LSI^9135880384||||||^MARTINEZ^JOHN D||||||202010270952|||F
OBX|1|CE|6320-6^B burgdor IgG Ser Ql IB^LN^5744^IgG Immunoblot^L^2.40^U||260385009^Negative^SCT||Negative||||F|||202010221439|24D1040592^Mayo Clinic Labs-Roch Superior Dr^L||||20201027095200||||MCLab-RO Superior Dr^A^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D1040592|3050 Superior Drive NW^Level 1^Rochester^MN^55901^USA^L
OBX|2|CE|13502-0^B burgdor IgG Patrn Ser IB-Imp^LN^2992^IgG detected against:^L^2.40^U||260413007^None^SCT|^^^kDa^kDa^L^^V1|||||F|||202010221439|24D1040592^Mayo Clinic Labs-Roch Superior Dr^L||||20201027095200||||MCLab-RO Superior Dr^A^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D1040592|3050 Superior Drive NW^Level 1^Rochester^MN^55901^USA^L
OBX|3|CE|6321-4^B burgdor IgM Ser Ql IB^LN^23931^IgM Immunoblot^L^2.40^U||10828004^Positive^SCT||Negative|A^Abnormal^HL70078^A^Abnormal^L^2.7^V1|||F|||202010221439|24D1040592^Mayo Clinic Labs-Roch Superior Dr^L||||20201027095200||||MCLab-RO Superior Dr^A^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D1040592|3050 Superior Drive NW^Level 1^Rochester^MN^55901^USA^L
OBX|4|ST|13503-8^B burgdor IgM Patrn Ser IB-Imp^LN^23932^IgM detected against:^L^2.40^U||p41,p39|^^^kDa^kDa^L^^V1|||||F|||202010221439|24D1040592^Mayo Clinic Labs-Roch Superior Dr^L||||20201027095200||||MCLab-RO Superior Dr^A^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D1040592|3050 Superior Drive NW^Level 1^Rochester^MN^55901^USA^L
OBX|5|ST|12781-1^B burgdor Ab Patrn Ser IB-Imp^LN^6241^Interpretation^L^2.40^U||See comment for results||||||F|||202010221439|24D1040592^Mayo Clinic Labs-Roch Superior Dr^L||||20201027095200||||MCLab-RO Superior Dr^A^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D1040592|3050 Superior Drive NW^Level 1^Rochester^MN^55901^USA^L
NTE|1|L|IgM-class antibodies to B. burgdorferi (Lyme disease)
NTE|2|L|detected.  Results are consistent with acute or recent
NTE|3|L|infection with B. burgdorferi.  Testing of a new specimen
NTE|4|L|collected in 7-14 days to demonstrate IgG seroconversion
NTE|5|L|may be considered to confirm infection if the diagnosis is
NTE|6|L|in doubt.
NTE|7|L
NTE|8|L|IgM immunoblot results should only be considered as
NTE|9|L|indicative of recent infection in patients presenting
NTE|10|L|within 30 days of symptom onset. Consideration of IgM
NTE|11|L|immunoblot results in patients with symptoms lasting >30
NTE|12|L|days is discouraged due to the risk of false positive IgM
NTE|13|L|immunoblot results and/or prolonged IgM seropositivity
NTE|14|L|following disease resolution.
NTE|15|L|Per CDC criteria, the Lyme IgG Immunoblot is interpreted as
NTE|16|L|positive if IgG-class antibodies are detected to >=5 B.
NTE|17|L|burgdorferi proteins, and the Lyme IgM Immunoblot is
NTE|18|L|interpreted as positive if IgM-class antibodies are
NTE|19|L|detected to >=2 B. burgdorferi proteins. Immunoblot
NTE|20|L|patterns not meeting these criteria should not be
NTE|21|L|interpreted as positive. Epitopes from certain B.
NTE|22|L|burgdorferi proteins (e.g., p41) are conserved across other
NTE|23|L|bacteria, which may lead to the detection of IgM- and/or
NTE|24|L|IgG-class antibodies on the Lyme disease immunoblots in
NTE|25|L|patients without Lyme disease. Immunoblot should only be
NTE|26|L|ordered on specimens that are positive or equivocal by a
NTE|27|L|FDA-licensed Lyme disease antibody screening test (e.g.,
NTE|28|L|EIA). Results of the Lyme IgM immunoblot should not be
NTE|29|L|considered in patients with >= 30 days of symptoms.
SPM|1|H65126&Placer_LIS&2.16.840.1.113883.3.2.12.1.99&ISO^F722049201&Mayo_LIS&2.16.840.113883.1.3.2.11.1&ISO||119364003^Serum specimen (specimen)^SCT^Serum^Serum^L^07/31/2012^v1|||||||P^Patient^HL70369^P^Patient^L^2.5.1^V1|1^{#}&Number&UCUM&unit&unit&L&1.1&V1|||||202010221439|202010231452
OBR|2|H65126^Placer Order Number^2.16.840.1.113883.3.2.12.1.99^ISO|F722049201^Filler Order Number^2.16.840.1.113883.3.2.12.1.1^ISO|^^^LYME^Lyme Disease Serology, S^L^^U|||202010221439|||7009204^Univ of Kansas Hosp-LSI^9135880384||||||^MARTINEZ^JOHN D||||||202010231453|||F
OBX|1|CE|20449-5^B burgdor Ab Ser Ql IA^LN^LYME^Lyme Disease Serology, S^L^2.40^U||10828004^Positive^SCT||Negative||||F|||202010221439|24D1040592^Mayo Clinic Labs-Roch Superior Dr^L||||20201023145200||||MCLab-RO Superior Dr^A^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D1040592|3050 Superior Drive NW^Level 1^Rochester^MN^55901^USA^L
NTE|1|L|Not diagnostic. Supplemental testing by immunoblot has
NTE|2|L|been ordered by reflex.
SPM|1|H65126&Placer_LIS&2.16.840.1.113883.3.2.12.1.99&ISO^F722049201&Mayo_LIS&2.16.840.113883.1.3.2.11.1&ISO||119364003^Serum specimen (specimen)^SCT^Serum^Serum^L^07/31/2012^v1|||||||P^Patient^HL70369^P^Patient^L^2.5.1^V1|1^{#}&Number&UCUM&unit&unit&L&1.1&V1|||||202010221439|202010231028